The relationship of serum antibody to respiratory syncytial virus (RSV) and risk of RSV infection was prospectively evaluated in frail elderly persons. Baseline blood samples from 22 subjects who developed symptomatic RSV infection during the 26-month study and from 22 control subjects who did not become infected with RSV were compared. The mean serum IgG titer to RSV fusion protein was significantly lower in the RSV-infected group than in the controls (15.4 { 1.6 vs. 16.4 { 1.8, P Å .05), as were the neutralizing titers to group A RSV (12.4 { 2.2 vs. 14.2 { 2.2, P Å .008) and group B virus (9.1 { 2.1, vs. 10.3 { 1.5, P Å .01). These results suggest that older adults with low titers of serum neutralizing antibody may be at greater risk of developing symptomatic RSV infection than those who have high antibody titers.
The relationship of serum antibody to respiratory syncytial virus (RSV) and risk of RSV infection was prospectively evaluated in frail elderly persons. Baseline blood samples from 22 subjects who developed symptomatic RSV infection during the 26-month study and from 22 control subjects who did not become infected with RSV were compared. The mean serum IgG titer to RSV fusion protein was significantly lower in the RSV-infected group than in the controls (15.4 { 1.6 vs. 16.4 { 1.8, P Å .05), as were the neutralizing titers to group A RSV (12.4 { 2.2 vs. 14.2 { 2.2, P Å .008) and group B virus (9.1 { 2.1, vs. 10.3 { 1.5, P Å .01). These results suggest that older adults with low titers of serum neutralizing antibody may be at greater risk of developing symptomatic RSV infection than those who have high antibody titers.
the centers for an average of 3 days per week. Enrollment was Respiratory syncytial virus (RSV), which was once thought ongoing throughout the study period.
to be a significant pathogen only in young children, is now Study design. Serum for immunologic assays was obtained appreciated as a serious problem in elderly adults [1, 2] . Similar from volunteers on enrollment. Subjects were evaluated for any to influenza, RSV has been associated with excess morbidity acute respiratory illness that occurred during the following 26-and mortality in persons aged ú65 years, particularly those month study (February 1992 to April 1994 . When a respiratory with underlying heart and lung disease [3] . The reasons for illness was identified by the day care staff, a nasopharyngeal samsevere illness in older persons are not completely understood ple was obtained for viral culture, and a convalescent blood sample but may be related to a declining immune system and the was taken 4 weeks later. During the 2 years of the study, 28 RSV presence of chronic medical conditions. Protective immunity illnesses were identified by either positive culture or serology. Six against RSV infection is complex, and the importance of serum subjects who had a single illness associated with a significant rise antibody is controversial [4] . However, animal and human data in antibody to RSV and to another viral pathogen were excluded suggest that serum neutralizing antibody to RSV may modify from analysis since the timing of their RSV illness was uncertain. Twenty-two subjects were selected as a control group and were disease severity and play a role in prevention of reinfection matched by age, sex, and the availability of a baseline serum drawn [5] . Few data are available on the immune status in response at approximately the same time as the subjects with RSV. To to RSV in the older adult. The purpose of this study was to maximize the likelihood that controls were exposed to RSV, they examine the relationship of serum antibody to RSV and the were also selected on the basis of attendance at the same center risk of RSV infection in frail elderly persons. during the same 2-week period. Controls also included subjects who had an illness evaluated during that period and whose convalescent sera did not show a §4-fold rise in RSV titers. This reduced
Materials and Methods
the possibility that controls could have had undetected or asympSubjects. Volunteers were recruited from three adult day care tomatic RSV infection. Pre-illness serum IgG to specific RSV centers in Rochester. The centers provide social and medical serproteins (by EIA) and serum RSV neutralizing activity were comvices to frail elderly persons who are eligible for nursing home pared between groups. admission by New York Medicaid standards. Participants attend Cultures. Nasopharyngeal secretions for viral culture were inoculated onto HEp-2 cell cultures within 4 h of collection, incubated at 35ЊC, and examined for cytopathic effect daily for 10 days. All terminal cultures were examined for RSV by an IFA using a mixture of RSV-specific monoclonal antibodies. RSV iso-lates were typed as group A or B using group-specific monoclonal and the human experimentation guidelines of the US Department of Health antibodies to the attachment (G) protein.
and Human Services were followed.
EIA. Serum IgG to the purified fusion (F) and attachment pro- by EIA, using standard methods [6] . Two-fold dilutions (1:800- 100 mL of HEp-2 cells (10 5 /mL) was added, and plates were incubated at 37ЊC. After 3 days, the plates were acetone-fixed and developed using RSV-specific mouse monoclonal antibody followed by horseradish peroxidase goat anti-mouse IgG and sub-EIA and RSV serum neutralizing titers for each group are strate. The neutralization titer was defined as the highest dilution shown in table 1. The mean baseline EIA-F titer of the RSVthat resulted in a 50% reduction in color compared with control infected group was 2-fold lower than that of the control group wells containing virus without serum.
(15.4 { 1.6 vs. 16.4 { 1.8, P Å .05), whereas the EIA G A and Data analysis. Proportions were compared using x 2 with G B titers were similar for the 2 cohorts. The mean MNA and
Yates's correction factor. Comparisons of mean log 2 titers were MNB titers were also significantly lower in the RSV-infected done using t test, and correlations were determined using linear group than in the controls. The MNA and MNB titers of all regression.
44 subjects correlated well (r Å .67, P õ .001), as did the MNA and EIA-F titers (r Å .54, P õ .001). There was a weaker Results but still significant correlation between MNB and EIA-F titers (r Å .33, P Å .03). In addition, MNA correlated with EIA-G A A total of 244 subjects was enrolled in the study and experititers (r Å .33, P Å .03), and MNB titers correlated with EIAenced 265 respiratory infections during the 26 months of study.
G B titers (r Å .42, P Å .004). As expected, there was no Nine men and 13 women had a respiratory illness with RSV correlation of G A and G B titers with the neutralizing titers of documented as the sole pathogen. Of the 22 illnesses, 9 were the opposite group. Although there was substantial overlap culture-positive and 13 were culture-negative and demonstrated of serum neutralizing titers between the 2 groups, there was a §4-fold rise in RSV-specific IgG as measured by EIA. Of segregation at the lowest and highest titers for both MNA and the 9 culture-positive subjects, 8 had convalescent sera avail-MNB ( figure 1 ). At the low end of the MNA spectrum (titer able and all showed a §4-fold rise in RSV antibody by EIA.
£10.64), 6 (86%) of 7 became infected with RSV, while at The 22 control subjects had paired sera from illnesses during the high end ( §15.64), only 2 (18%) of 11 became infected the same time period that were negative for RSV infection by (P Å .02, x 2 ). the screening EIA assay. The mean number of days in surveil-
The neutralizing and EIA titers of the RSV culture -positive lance was not significantly different between the RSV and the persons and seropositive-only persons were analyzed separately control groups (543 vs. 527) .
to determine if there was a difference between these groups. Nine (41%) of 22 illnesses could be typed by RSV group; Both the mean MNA and MNB titers of the 9 culture-positive 4 RSV isolates were group A and 5 were group B. The 2 subjects were lower than the titers of the 13 persons with positive cultures from year 1 were group B isolates, and both serologically diagnosed infections (MNA: 11.4 { 2.2 vs. 13.1 group A and B viruses were identified during the second season.
{ 2.1; MNB: 8.6 { 2.4 vs. 9.8 { 1.5); however, these differOf the 5 group B -infected patients, 3 had §4-fold responses ences were not significant. to G A and 4 had G B responses. Similarly, of the 4 group Ainfected subjects, 4 had a §4-fold response to G A and 2 had significant rises in titers to G B . Thus, it is not possible to Discussion differentiate group A and B infection by serologic response alone in RSV reinfections.
The results of this study demonstrate that the mean baseline neutralizing titers to RSV were lower in subjects who subseFifty-five percent of both the RSV-infected and control groups were women; the mean age for both cohorts was 78 { quently experienced symptomatic RSV infection than in matched controls who had non-RSV illnesses during the same 9 years. Baseline blood samples were collected for all subjects 135 { 122 (mean { SD) days prior to the illness (range, 0 -time period. Despite the small number of RSV illnesses evaluated, there was a statistically significant difference in the mean 383), and there was no significant difference between the RSVinfected and control groups (123 { 127 vs. 148 { 119).
EIA-F and neutralization titers of the infected group compared / 9d3f$$fe26 12-23-97 08:53:41 jinfa UC: J Infect with titers in the uninfected group. These findings suggest that protects rodents against RSV challenge, as does immunization with these glycoproteins [8] . Glezen et al., in a study of infants, elderly adults with low serum neutralizing titers to RSV may be more likely to develop symptomatic RSV infection than demonstrated that neutralizing titers in cord sera correlated inversely with risk of hospitalization due to RSV infection [9] . elderly persons with higher titers.
Although controversial, current data suggest that circulating In a subsequent study, the same investigators showed that the risk of reinfection with RSV was inversely related to the level neutralizing antibody to RSV is beneficial. Passive transfer of neutralizing monoclonal antibodies to the F and G proteins of neutralizing antibody [10] . In a study of experimental rein-/ 9d3f$$fe26 12-23-97 08:53:41 jinfa UC: J Infect
